Willingness to pay for treatment with highly active antiretroviral (HAART) drugs: A rural case study in Cameroon

Sahara J

Volumn 1, Issue 2, 2004, Pages 107-113

  Muko, Kenneth Ngwambokong ^a   Ngwa, Valentine Che ^b   Chigang, Leslie ^c   Ngwa, Igbinosum Gladys ^d   Meiburg, Anke ^d   Shu, Elvis Neba ^e  

^a Catholic Health Service of the archdiocese of Bamenda   (Cameroon)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c St Louis Clinic Bamenda   (Cameroon)

^d St Martin de Porres Hospital   (Cameroon)

^e UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Access to antiretrovirals; Affordability; Drug costs; HIV AIDS; Treatment

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; ATTITUDE TO HEALTH; CAMEROON; COST OF ILLNESS; ECONOMICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; POVERTY; RURAL POPULATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTITUDE TO HEALTH; CAMEROON; COST OF ILLNESS; HIV INFECTIONS; HUMANS; MIDDLE AGED; POVERTY; RURAL POPULATION;

EID: 34247653928     PISSN: 17290376     EISSN: 18134424     Source Type: Journal    
DOI: 10.1080/17290376.2004.9724833     Document Type: Article

References (15)

1. Alcorn, K. (1995). Slow progress against HIV. AIDS Action, 20, 2-3.
2. Bentley, M., Spratt, K. & Shepherd, K. (1998). HIV testing and counseling among men attending sexually transmitted disease clinics in Pune, India: changes in condom use and sexual behavior over time. AIDS, 12, 1869-1877.
3. Berwick, D.M. (2001, June 26). We all have AIDS. Washington: Washington Post, A17.
4. Chingang, L.C. (2002).The need for implementation of local health insurance policies. Biodiagnostics and Therapy, 16, 43-45.
5. Farmer, P. & Jy, K. (1998). Community approaches to the control of multiresistant tuberculosis: introducing the DOTS-plus. British Medical Journal, 317, 671-674.
6. Farmer, P., Leandre, F., Mukherjee, J.S., Claude, M.S., Nevil, P., Smith, F. et al. (2000). Community-based approaches to HIV treatment in resource poor settings. Lancet, 358, 404-409.
7. Hay, J.W., Osmond D.H. & Jacobson, M.A. (1998). Projecting the Medical Costs of AIDS and ARC in the United States. Journal of AIDS, 1(5), 466-485.
8. Martin, A. (1996).The cost of HIV/AIDS care. In J. Mann & D.Tarantola (Eds), AIDS in the World II, Chapter 36. New York: The World Bank.
9. Marseille, E., Kahn, J.G., Mmiro, F., Gauy, L., Musoke, P., Glenn Fowler, M. & Brooks Jackson, J. (1999). Cost effectiveness of single dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-saharan Africa. Lancet, 354, 803-809.
10. Muko, K.N., Bangsi, A. (2002). Census report on orphans in Njinikom. Intercare/Njinikom Project Hope. Bamenda: Charity Press.
11. Muko, K.N., Ngwa, V.C, Chingang, L.C. & Meiburg, A. (2002). How costly is HAART? Unpublished manuscript.
12. Pronyk, P.M., Kim, J. & Porter, D.H. (2001).Whose priorities? A response to the issue of antiretrovirals in Africa. Tropical Medicine and International Health, 6(8), 575-577.
13. Prescott, N. (1997). Setting priorities for government involvement in antiretrovirals in the implications of antiretroviral treatments; informal consultations. Geneva: WHO.
14. UNAIDS (1997). Prevention of HIV transmission from mother to child: strategic options. Geneva: UNAIDS.
15. UNAIDS (2002). Report on the global HIV/AIDS epidemic. Geneva: UNAIDS